首页> 外文学位 >Measurement and control of the flow of protein solutions in a micro-fluidic macro-molecular crystallizer.
【24h】

Measurement and control of the flow of protein solutions in a micro-fluidic macro-molecular crystallizer.

机译:在微流态大分子结晶器中测量和控制蛋白质溶液的流量。

获取原文
获取原文并翻译 | 示例

摘要

X-ray crystallography provides vital information regarding a protein's 3D structure. However, in order to perform X-ray crystallography, one needs to be able to grow large, defect-free crystals.; A major drawback of currently used lab scale techniques for crystallization is that it is very difficult to control the state of the crystallization volume after start-up. However, if controlled amounts of very small volumes could be added to or removed from this volume, we should be able to grow better crystals. However, the flow-rates needed to achieve such control are as low as a few picoliters per second. So far, controlled delivery of such low volumes (flow-rates) has not, to our knowledge, been tried.; The Crystallization Micro-Array (CRYMA) is being designed do so. It shall consist of reservoirs of protein, precipitant, and buffer solution that will be connected to a large number of micro-reactors via pumps and flow meters, which will control the delivery of each solution to each micro-reactor. A major part of the effort has been directed towards the development of a flow-sensor that can be incorporated into the CRYMA---the Lag After Pulsed Separation (LAPS) meter. An upstream event (electrophoretic separation of concentration of the particles in one section of the device) is detected downstream (by change in AC resistance). The time lag between the event and the detection is inversely proportional to the velocity, providing a non-invasive, no-moving-parts flow measurement. The LAPS meter can measure the flowrate of solutions containing one or more charged biomacromolecules or particles. It could also be utilized for other purposes, such as in Micro-Total Analysis Systems (m-TAS), operating micro-bioreactors, drug delivery, and in micro-dosing systems for performing drug assays on a small number of cells.; The flow rate of each solution through each pump will be controlled to maintain a different concentration vs. time profile in each reactor of the CRYMA. We have also looked at how feed rates of protein and salt affect the likelihood of obtaining large protein crystals, and have suggested a method to calculate the optimal feed profiles to maximize the average crystal size obtained in the reactor.
机译:X射线晶体学提供有关蛋白质3D结构的重要信息。然而,为了进行X射线晶体学,需要能够生长大的,无缺陷的晶体。当前用于结晶的实验室规模技术的主要缺点是在启动后很难控制结晶体积的状态。但是,如果可以在此体积中添加或删除受控量的非常小的体积,则我们应该能够生长出更好的晶体。但是,实现这种控制所需的流速低至每秒几皮升。到目前为止,据我们所知,还没有尝试过控制如此小量(流量)的输送。正在设计结晶微阵列(CRYMA)。它应由蛋白质,沉淀剂和缓冲溶液组成,这些溶液将通过泵和流量计连接到大量微型反应器,以控制每种溶液向每个微型反应器的输送。努力的主要方向是开发可以集成到CRYMA中的流量传感器-脉冲分离滞后(LAPS)流量计。在下游(通过交流电阻的变化)检测到上游事件(设备一个区域中颗粒浓度的电泳分离)。事件与检测之间的时间滞后与速度成反比,从而提供了无创,无运动的流量测量。 LAPS仪表可以测量包含一种或多种带电生物大分子或颗粒的溶液的流速。它也可以用于其他目的,例如在微量总分析系统(m-TAS),运行中的微型生物反应器,药物输送以及用于在少量细胞上进行药物测定的微量给药系统中。将控制通过每个泵的每种溶液的流速,以在CRYMA的每个反应器中维持不同的浓度与时间的关系。我们还研究了蛋白质和盐的进料速率如何影响获得大的蛋白质晶体的可能性,并提出了一种计算最佳进料曲线以最大化反应器中获得的平均晶体尺寸的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号